Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen.
about
HIV-1 integrase inhibitor resistance and its clinical implicationsImpact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patientsHIV-1 genetic variation and drug resistance development.Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysisExtended use of raltegravir in the treatment of HIV-1 infection: optimizing therapyEmerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis.
P2860
Q24628743-470AA0E5-500E-4015-9116-EC980781DF24Q28483630-6D4712B5-474E-4957-B62B-03182E7D8A31Q30354857-2923771E-67F9-41A6-B800-5E2BE1FC6D7FQ33988153-C2319BCC-4C13-4A8C-9FF7-5F71F47CD13DQ35026582-9601E8BD-66CA-46EF-BAB3-BDE55B21715BQ35693353-E88954FF-9819-49E0-9CFF-49555ADF7249Q41441059-74947CC2-49D0-448D-9D55-3653045ED6ADQ42287383-AC45907F-D0EF-4971-90BC-E9C8E5DC0372Q43601186-D1F2DEA3-8D69-40B3-9FFE-206871432EC0
P2860
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@en
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@nl
type
label
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@en
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@nl
prefLabel
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@en
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@nl
P2093
P50
P1433
P1476
Resistance analyses in highly ...... d darunavir/ritonavir regimen.
@en
P2093
ANRS 139 TRIO Trial study group
Anne-Marie Taburet
Bénédicte Roquebert
Catherine Fagard
Christine Jacomet
Céline Colin
Jean-Michel Molina
Yazdan Yazdanpanah
P304
P356
10.1097/QAD.0B013E32833ED2A7
P407
P577
2010-11-01T00:00:00Z